GB Patent
GB2042888B — Preparation for administration to the mucosa of the oral or nasal cavity
Assigned to Teijin Ltd · Expires 1983-09-28 · 43y expired
What this patent protects
Patent listed against Subutex.
Drugs covered by this patent
- Subutex (Buprenorphine Hydrochloride) · Indivior
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.